New Zealand markets open in 9 hours 4 minutes

DMK Pharmaceuticals Corporation (DMKPQ)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0293-0.0039 (-11.88%)
At close: 03:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 360.58k
Enterprise value -122.43k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.03
Price/book (mrq)7.86
Enterprise value/revenue 14.10
Enterprise value/EBITDA -0.71

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3-98.24%
S&P500 52-week change 326.24%
52-week high 38.2800
52-week low 30.0293
50-day moving average 30.0358
200-day moving average 30.3379

Share statistics

Avg vol (3-month) 329.24k
Avg vol (10-day) 38.67k
Shares outstanding 510.09M
Implied shares outstanding 610.09M
Float 810.08M
% held by insiders 19.26%
% held by institutions 10.00%
Shares short (12 Jan 2024) 4211.9k
Short ratio (12 Jan 2024) 40.12
Short % of float (12 Jan 2024) 42.31%
Short % of shares outstanding (12 Jan 2024) 42.10%
Shares short (prior month 15 Dec 2023) 492.28k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:70
Last split date 322 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-34,740.36%

Management effectiveness

Return on assets (ttm)-102.41%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.62M
Revenue per share (ttm)1.03
Quarterly revenue growth (yoy)-99.40%
Gross profit (ttm)N/A
EBITDA -16.65M
Net income avi to common (ttm)-21.33M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.66M
Total cash per share (mrq)0.66
Total debt (mrq)63.21k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.58
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-9.38M
Levered free cash flow (ttm)1.17M